Eli Lilly and Company
6-fluoro-2-methylbenzo[d]thiazol-5-yl compounds
Last updated:
Abstract:
The present invention provides a compound of Formula I: ##STR00001## wherein R is hydrogen or methyl; and Z is: ##STR00002## or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimer's disease.
Status:
Grant
Type:
Utility
Filling date:
28 Jul 2020
Issue date:
17 Nov 2020